BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22898238)

  • 1. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
    Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acceptance and understandability of various methods of health valuations for the chronically ill: willingness to pay, visual analogue scale and rating scale].
    Meder M; Farin E
    Gesundheitswesen; 2009 Nov; 71(11):e62-71. PubMed ID: 20094981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
    Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
    BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
    Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
    Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of willingness to pay for implantable cardioverter-defibrillator therapy.
    Nowakowska D; Guertin JR; Liu A; Abrahamowicz M; Lelorier J; Lespérance F; Brophy JM; Rinfret S
    Am J Cardiol; 2011 Feb; 107(3):423-7. PubMed ID: 21257009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay and quality of life in patients with rosacea.
    Beikert FC; Langenbruch AK; Radtke MA; Augustin M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):734-8. PubMed ID: 22583164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.
    Li C; Zeliadt SB; Hall IJ; Smith JL; Ekwueme DU; Moinpour CM; Penson DF; Thompson IM; Keane TE; Ramsey SD
    Value Health; 2012; 15(5):716-23. PubMed ID: 22867781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for health improvements of physical activity on prescription.
    Romé A; Persson U; Ekdahl C; Gard G
    Scand J Public Health; 2010 Mar; 38(2):151-9. PubMed ID: 20064920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying factors that affect patients' willingness to pay for inhaled insulin.
    Pinto SL; Holiday-Goodman M; Black CD; Lesch D
    Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for a hearing aid: comparing the payment scale and open-ended question.
    Grutters JP; Anteunis LJ; Chenault MN; Joore MA
    J Eval Clin Pract; 2009 Feb; 15(1):91-6. PubMed ID: 19239587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to pay for potential enhancements to a low-cost cataract surgical package in rural southern China.
    Ko F; Frick KD; Tzu J; He M; Congdon N
    Acta Ophthalmol; 2012 Feb; 90(1):e54-60. PubMed ID: 21801337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay: a valid and reliable measure of health state preference?
    O'Brien B; Viramontes JL
    Med Decis Making; 1994; 14(3):289-97. PubMed ID: 7934716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.